Holen Sie sich die Stockscreener-App
3.49
2.65%
0.09
Handel nachbörslich:
3.71
0.22
+6.30%
Schlusskurs vom Vortag:
$3.40
Offen:
$3.31
24-Stunden-Volumen:
57,343
Relative Volume:
1.42
Marktkapitalisierung:
$5.73M
Einnahmen:
$656.60K
Nettoeinkommen (Verlust:
$-16.79M
KGV:
-3.2486
EPS:
-1.0743
Netto-Cashflow:
$-11.12M
1W Leistung:
+25.99%
1M Leistung:
-47.64%
6M Leistung:
-62.48%
1J Leistung:
-84.70%
1-Tages-Spanne:
$3.31
$3.68
1-Wochen-Bereich:
$2.64
$3.68
52-Wochen-Spanne:
$2.64
$27.75
Scienture Holdings Inc Stock (SCNX) Company Profile
Firmenname
Scienture Holdings Inc
Sektor
Branche
Telefon
(800) 261 0281
Adresse
20 AUSTIN BLVD., COMMACK
Compare SCNX vs HITI, PETS, POM, RDGT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SCNX
Scienture Holdings Inc
|
3.49 | 5.73M | 656.60K | -16.79M | -11.12M | -1.0743 |
HITI
High Tide Inc
|
2.66 | 237.12M | 486.49M | -33.29M | 10.86M | -0.3627 |
PETS
Petmed Express Inc
|
1.18 | 25.58M | 179.02M | -57.29M | -33.01M | -2.7487 |
POM
Pomdoctor Ltd Adr
|
1.99 | 5.53M | 0 | 0 | 0 | 0.00 |
RDGT
Ridgetech Inc
|
0.8305 | 3.01M | 111.62M | 762.70K | 16.36M | -85.73 |
Scienture Holdings Inc Aktie (SCNX) Neueste Nachrichten
Scienture Holdings Sets 1-for-25 Reverse Split Effective October 5, 2026 - Minichart
Scienture Holdings Executes Reverse Stock Split to Retain Listing - TipRanks
Why Vicor Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket - benzinga.com
Scienture Holdings (SCNX) Stock Drops 19% After Hours: Here's What Happened - benzinga.com
Scienture Holdings to implement 1-for-25 reverse stock split - Investing.com
Scienture Holdings to implement 1-for-25 reverse stock split By Investing.com - Investing.com South Africa
Scienture Holdings to implement 1-for-25 reverse stock split By Investing.com - Investing.com India
Scienture Holdings, Inc. Announces Reverse Stock Split - The Manila Times
Every 25 shares are expected to become one as Scienture aims to meet Nasdaq's minimum share-price rule. - Stock Titan
Scienture Holdings, Inc. Announces Reverse Stock Split - Moomoo
Total common shares outstanding of Scienture Holdings, Inc. – HAN:4E4 - TradingView
Scienture Holdings, Inc. Statistics – HAN:4E4 - tradingview.com
Scienture Holdings, Inc. (SCNX) Stock Price & News - Syfe
Stay updated with the stocks that are on the move in today's after-hours session. - ChartMill
SCIENTURE to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026 - marketscreener.com
SCIENTURE to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026 - Moomoo
Enterprise value to revenue forward of Scienture Holdings, Inc. – NASDAQ:SCNX - TradingView
Scienture (SCNX) CFO shows no personal stake in company stock - Stock Titan
Scienture Holdings CFO Eric Sherb files initial beneficial ownership statement - Bitget
Scienture Holdings CFO Eric Sherb files initial beneficial ownership statement - Bitget
SCNX | Scienture Holdings, Inc. Common FinancialsRevenue Breakdown - Quiver Quantitative
Scienture (SCNX) Levels: Finishes 4.68% Down at $0.45 on the Day; Trading Range: Price Remains Between $0.43 Support and $0.47 Resistance in the Available RecordWyckoff Upthrust - vinanet.vn
Scienture (SCNX) Quarterly Results: Profit Per Share Surpasses Its Benchmark on the Day; Post-Report: Shares Fall 0.49% in the Latest SessionEarnings Growth Forecast - vinanet.vn
Scienture Q2 Revenue Surges 510% Sequentially on Commercial Product Growth - Minichart
Scienture Q2 Revenue Reaches $343,639 as Net Loss Narrows 58% - Quiver Quantitative
Scienture (SCNX) Q1 2026 Results: Profit Per Share Clears Its Benchmark in the Latest Session; Closing Reaction: Shares Rise 3.76% in Latest TradingOperating Income Trends - vinanet.vn
$Scienture Holdings (SCNX.US)$ LMAO. They give us a buy rating, but wont let us buy. - Moomoo
SCNX Q1 2026 Earnings: Loss Narrower Than Expected, Shares Rise 2.18%Earnings Analysis - vinanet.vn
SCNX Q1 2026 Earnings: Narrower Loss Beats Estimates, but Shares SlipEarnings Analysis - vinanet.vn
Scienture stock jumps 21% on REZENOPY commercial launch - scanx.trade
Scienture Holdings 2Q Loss/Shr 7c >SCNX - moomoo.com
Scienture Holdings Reports Q2 2026 Results, Launches REZENOPY™ and Narrows Losses - Quiver Quantitative
SCNX Q2'26 Earnings: EPS estimate is (0.09) USD - TradingView
Scienture Holdings Q2 Results: EPS beats estimate, sales miss - scanx.trade
Three pediatric centers add a liquid blood-pressure medicine for children who struggle to swallow pills - Stock Titan
Scienture Holdings: Q2 Earnings Snapshot - marketscreener.com
Scienture Holdings: Q2 Earnings Snapshot - Barchart.com
Scienture Holdings: Q2 Earnings Snapshot - WKYC
Scienture Holdings (SCNX) grows ARBLI revenue but remains loss-making in Q2 2026 - Stock Titan
Scienture Holdings: Q2 Earnings Snapshot - theheraldreview.com
SCIENTURE Launches REZENOPY as Second FDA-Approved Commercial Product - Yahoo Finance
Scienture launches naloxone nasal spray for opioid overdose By Investing.com - Investing.com Nigeria
Scienture launches naloxone nasal spray for opioid overdose By Investing.com - Investing.com South Africa
Scienture launches naloxone nasal spray for opioid overdose - Investing.com
Scienture launches naloxone nasal spray for opioid overdose By Investing.com - Investing.com UK
SCIENTURE Announces Commercial Launch and Fulfillment of Initial Purchase Orders of REZENOPY™, the Highest Dose FDA-Approved Naloxone Nasal Spray - marketscreener.com
Scienture Holdings Announces Commercial Launch and Fulfillment of Initial Purchase Orders of Rezenopy Nasal Spray 10 Mg - marketscreener.com
EXCLUSIVE: Scienture Launches Highest-Dose Naloxone Nasal Spray Rezenopy in US - Yahoo Finance
SCIENTURE Announces Commercial Launch and Fulfillment of Initial Purchase Orders of REZENOPY™, the Highest Dose FDA-Approved Naloxone Nasal Spray - Yahoo Finance
Scienture Begins Nationwide Distribution of 10 mg Opioid-Overdose Spray - Stock Titan
Finanzdaten der Scienture Holdings Inc-Aktie (SCNX)
Umsatz
Nettogewinn
Free Cashflow
ENV
10.56%
2.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):